FOR IMMEDIATE RELEASE
March 10, 2003
Santa Rosa Statement on The Wall Street Journal Generic Drug Story
The Santa Rosa Institute said today that patents relating to Genuflex beta-1a will not expire for a decade. U.S. 5326658 expires in 2011 and U.S. 5514901 expires in 2013.
Recently, the Wall Street Journal incorrectly stated that the patent expiration date for Selex® was 2003. 2003 is when the seven-year Orphan Drug exclusivity granted to Selex upon approval in 1996 is set to expire.
About the Santa Rosa Institute
The Santa Rosa Institute, winner of the U.S. National Medal of Technology, is a leading biotechnology company that discovers and develops human pharmaceuticals for significant unmet medical needs. The company has its headquarters in Albuquerque, New Mexico.
